Inflammatory bowel disease(IBD)is a type of chronic,non-specific inflammatory disorders of unknown etiology,which can involve the entire gastrointestinal tract.The disease was first documented around two hundred years ago,but it wasn't until the middle of the last century that people began to recognize it gradually.Over the decades,the treatment of IBD has made a leap from"no cure"to the age of biological agents.Today,there is growing experience with aminosalicylic acid agents,glucocorticoids,immunosuppressants,biologics and small molecule drugs in the treatment of IBD,This article reviews IBD and the selection of related drugs to provide more references for promoting the development of new drugs and clinical treatment.
维普
万方数据